<DOC>
	<DOCNO>NCT01032018</DOCNO>
	<brief_summary>Patients consent screen within 2 6 month index ACS . Patients elevated depression ( BDI &gt; =15 BDI &gt; =10 assess twice two week period ) continue meet trial 's eligibility criterion consent . Through informed consent , arm trial describe equipoise approach postACS depression care . Patients consent randomization enrol treatment trial . The intervention phase 6 month , hence final outcome assessment perform approximately 9 month index ACS . Interim measure depression obtain 2 4 month post-enrollment . Major adverse cardiac event all-cause mortality also ascertain 6 month post-enrollment . Quality assurance independent medical event adjudication committee use prospective guideline employ .</brief_summary>
	<brief_title>Comparison Depression Interventions After Acute Coronary Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Hospitalized ACS define unstable angina MI BDI great equal 10 &lt; 15 26 month postACS 2 occasion , BDI great 15 one occasion Age least 35 year Fluent English Spanish Able complete baseline assessment within 26 month index ACS event Able willing provide inform consent Presence noncardiac condition likely terminate fatally within 1 year Inaccessibility intervention followup ( e.g. , plan move area ) Cognitive impairment Need immediate psychiatric intervention ( i.e. , require hospitalization psychiatric intervention within 72 hour ) Suicidal ideation Major psychiatric comorbidity ( current history ) include active psychosis , bipolar disorder , overt personality disorder Active substance abuse dependency Chronic renal failure ( receive chronic dialysis treatment , estimate glomerular filtration rate '' â€¦ [ eGFR ] &lt; 30 ml/min/1.73 m2 ) moderate/severe liver disease ( e.g. , esophageal varix , portal hypertension , encephalopathy , GI bleed ) Participation another clinical trial treatment depression .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Acute coronary syndrome</keyword>
	<keyword>Depression</keyword>
	<keyword>Satisfaction care</keyword>
</DOC>